Zunhua Yang

965 total citations
58 papers, 762 citations indexed

About

Zunhua Yang is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zunhua Yang has authored 58 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 22 papers in Organic Chemistry and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zunhua Yang's work include Cancer therapeutics and mechanisms (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Diabetes Treatment and Management (8 papers). Zunhua Yang is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Diabetes Treatment and Management (8 papers). Zunhua Yang collaborates with scholars based in China, South Korea and United States. Zunhua Yang's co-authors include Yuanying Fang, Pengwu Zheng, Shan Xu, Yi Jin, Wufu Zhu, Wufu Zhu, Haeil Park, Sai‐Sai Xie, Xin Sun and Zhihui Zhou and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Zunhua Yang

54 papers receiving 751 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zunhua Yang 368 348 121 105 98 58 762
Jiquan Zhang 410 1.1× 371 1.1× 118 1.0× 65 0.6× 48 0.5× 72 952
Xuewei Wu 693 1.9× 463 1.3× 127 1.0× 212 2.0× 70 0.7× 28 1.3k
Qianbin Li 467 1.3× 295 0.8× 31 0.3× 157 1.5× 135 1.4× 66 886
Kashif Haider 246 0.7× 334 1.0× 52 0.4× 74 0.7× 39 0.4× 23 643
Linxiang Zhao 631 1.7× 722 2.1× 99 0.8× 181 1.7× 46 0.5× 83 1.3k
Hanan S. Anbar 272 0.7× 224 0.6× 47 0.4× 105 1.0× 33 0.3× 45 605
Yuanying Fang 285 0.8× 234 0.7× 159 1.3× 72 0.7× 16 0.2× 54 663
Maocai Yan 493 1.3× 184 0.5× 123 1.0× 166 1.6× 25 0.3× 57 852
Ola I. A. Salem 217 0.6× 418 1.2× 62 0.5× 76 0.7× 35 0.4× 26 586
Kevin N. Dack 260 0.7× 221 0.6× 114 0.9× 99 0.9× 29 0.3× 22 683

Countries citing papers authored by Zunhua Yang

Since Specialization
Citations

This map shows the geographic impact of Zunhua Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zunhua Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zunhua Yang more than expected).

Fields of papers citing papers by Zunhua Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zunhua Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zunhua Yang. The network helps show where Zunhua Yang may publish in the future.

Co-authorship network of co-authors of Zunhua Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zunhua Yang. A scholar is included among the top collaborators of Zunhua Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zunhua Yang. Zunhua Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Fukang, Shu Shi, Huilan Li, et al.. (2025). Design, synthesis, and antidiabetic activities of 5-methoxypyrimidine derivatives targeting GPR119 and DPP-4. Bioorganic & Medicinal Chemistry. 129. 118318–118318.
2.
3.
Yang, Zunhua, et al.. (2024). Research progress of PROTACs for neurodegenerative diseases therapy. Bioorganic Chemistry. 147. 107386–107386. 11 indexed citations
4.
5.
Yang, Zunhua, Huilan Li, Guoliang Xu, et al.. (2023). Novel 2,6-disubstituted benzofuran-3-one analogues improve cerebral ischemia/reperfusion injury via neuroprotective and antioxidative effects. Bioorganic Chemistry. 132. 106346–106346. 9 indexed citations
6.
Xiao, Zhen, Zhihui Zhou, Qian Zhang, et al.. (2020). Discovery of thiapyran-pyrimidine derivatives as potential EGFR inhibitors. Bioorganic & Medicinal Chemistry. 28(19). 115669–115669. 25 indexed citations
7.
Zhang, Qian, Zhen Xiao, Xin Sun, et al.. (2019). Design, synthesis and biological evaluation of substituted 2-(thiophen-2-yl)-1,3,5-triazine derivatives as potential dual PI3Kα/mTOR inhibitors. Bioorganic Chemistry. 95. 103525–103525. 29 indexed citations
8.
Fang, Yuanying, Shaokun Zhang, Wenting Wu, et al.. (2019). Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators. Bioorganic Chemistry. 94. 103390–103390. 14 indexed citations
9.
McGuire, Timothy R., Donald W. Coulter, Dachang Bai, et al.. (2019). Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus. BMC Cancer. 19(1). 837–837. 11 indexed citations
10.
Bernatchez, Jean, Zunhua Yang, Jerry Li, et al.. (2018). Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus. Antimicrobial Agents and Chemotherapy. 62(10). 21 indexed citations
11.
Yang, Zunhua, et al.. (2018). Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors. Computational and Structural Biotechnology Journal. 16. 462–478. 9 indexed citations
12.
Fang, Yuanying, Jun Xu, Zhifeng Li, et al.. (2018). Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry. 26(14). 4080–4087. 30 indexed citations
13.
Liu, Jing, Jinshuai Lan, Yongbing Sun, et al.. (2018). Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation. Bioorganic Chemistry. 81. 512–528. 88 indexed citations
14.
Yang, Zunhua, Yuanying Fang, & Haeil Park. (2017). Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist. Bioorganic & Medicinal Chemistry Letters. 27(11). 2515–2519. 14 indexed citations
15.
Fang, Yuanying, Zunhua Yang, Hui Ouyang, et al.. (2016). Synthesis and biological evaluation of Hederacolchiside A1 derivatives as anticancer agents. Bioorganic & Medicinal Chemistry Letters. 26(19). 4576–4579. 13 indexed citations
16.
Fang, Yuanying, Rikang Wang, Mingzhen He, et al.. (2016). Nitric oxide-donating derivatives of hederacolchiside A1: Synthesis and biological evaluation in vitro and in vivo as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 27(1). 98–101. 16 indexed citations
17.
Yang, Zunhua, Yan Liu, Jongsam Ahn, et al.. (2016). Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents: Design, synthesis, pharmacokinetics and antibacterial activities. European Journal of Medicinal Chemistry. 124. 129–137. 17 indexed citations
18.
Yang, Zunhua, Yuanying Fang, Tuan-Anh Nguyen Pham, Jong‐Kook Lee, & Haeil Park. (2012). Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 23(5). 1519–1521. 20 indexed citations
19.
Yang, Zunhua, Tuyen Ngoc Truong, Tuan-Anh Nguyen Pham, et al.. (2012). Synthesis of 1,5-diarylhaloimidazole analogs and their inhibitory activities against PGE2 production from LPS-treated RAW 264.7 cells. Bioorganic & Medicinal Chemistry. 20(21). 6256–6259. 1 indexed citations
20.
Yang, Zunhua, Ji Yeon Lee, Tae Hyung Kim, et al.. (2011). Design, synthesis and anticancer activity of novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivatives. Bioorganic & Medicinal Chemistry Letters. 21(19). 5730–5734. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiquan Zhang Breakdown of academic impact, for papers by Xuewei Wu Breakdown of academic impact, for papers by Qianbin Li Breakdown of academic impact, for papers by Kashif Haider Breakdown of academic impact, for papers by Linxiang Zhao Breakdown of academic impact, for papers by Hanan S. Anbar Breakdown of academic impact, for papers by Yuanying Fang Breakdown of academic impact, for papers by Maocai Yan Breakdown of academic impact, for papers by Ola I. A. Salem Breakdown of academic impact, for papers by Kevin N. Dack
Rankless by CCL
2026